SCHEMBL24557147

SCHEMBL24557147

CC1(C)c2ccccc2-c2c1ccc1sc3ccccc3c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.44
TDP1 Q9NUW8 3/20 0.44
POLB P06746 2/20 0.44
MEN1 O00255 1/20 0.44
DUSP3 P51452 1/20 0.44
BLM P54132 1/20 0.44
PTPN5 P54829 1/20 0.44
KMT2A Q03164 1/20 0.44
PTPN11 Q06124 1/20 0.44
MCL1 Q07820 1/20 0.44
CTDSP1 Q9GZU7 1/20 0.44
GPR3 P46089 1/20 0.38
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
HPGD P15428 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19108382 0.93 MAPT (0.39) MAPTTDP1POLBMEN1DUSP3
SCHEMBL22920683 0.85 KDM4E (0.41) MAPTTDP1POLBMEN1DUSP3
SCHEMBL22920747 0.84 KDM4E (0.43) MAPTTDP1POLBMEN1DUSP3
SCHEMBL17932270 0.83 CHEK1 (0.37) MAPTTDP1POLBMEN1DUSP3
SCHEMBL19760318 0.83 MAPT (0.46) MAPTTDP1POLBMEN1DUSP3
SCHEMBL22011949 0.83 PARP14 (0.34) MAPTTDP1POLBMEN1DUSP3
SCHEMBL22920894 0.83 LIMK1 (0.36) MAPTTDP1POLBMEN1DUSP3
SCHEMBL22930614 0.82 MAPT (0.44) MAPTTDP1POLBMEN1DUSP3
SCHEMBL24518972 0.81 BRDT (0.33) MAPTTDP1POLBMEN1DUSP3
SCHEMBL20988546 0.81 MEN1 (0.34) MAPTTDP1POLBMEN1DUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220209132-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME Changchun Hyperions Technology Co., Ltd. (CN) 2022-06-30 US disclosed
EP-4019503-A2 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME Changchun Hyperions Technology Co., Ltd. (CN) 2022-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220209132-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME EML4, STOM, GJB2 MAPT 553/4885TDP1 3465/4885POLB 3255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.